Keyphrases
Frequency Factor
100%
Celiac Disease
100%
Risk Factors
100%
Human Leukocyte Antigen
66%
High Risk
41%
First-degree Relatives
33%
Second-degree Relatives
33%
Clinical picture
33%
Index Patient
25%
Rescreening
25%
Family Screening
25%
Healthcare
16%
Multivariable
16%
Incidence Rate
16%
Working Diagnosis
16%
Individual Risk Factors
16%
High-risk HPV
16%
Human Leukocyte antigen-DQ2
16%
Aging Effect
8%
Finland
8%
Randomly Distributed
8%
Diagnostic Performance
8%
Screening Study
8%
Cost-effectiveness
8%
Clinical Practice
8%
Age Groups
8%
Environmental Factors
8%
Small Intestine
8%
Gastrointestinal
8%
All Ages
8%
Gastrointestinal Diseases
8%
Genetic Risk
8%
Anemia
8%
Substantial Part
8%
Family Members
8%
Mucosal Damage
8%
Late Diagnosis
8%
Negative Screening
8%
Celiac Disease Diagnosis
8%
Wet Gluten
8%
Non-celiac
8%
Current Care Guidelines
8%
Sibling Pairs
8%
New Human Leukocyte Antigen Allele
8%
Human Leukocyte Antigen Genes
8%
Human Leukocyte Antigen Genotyping
8%
Malabsorption
8%
International Guidelines
8%
At-risk Relatives
8%
Follow-up Screening
8%
Optimal Age
8%
Negative Testing
8%
Immune-mediated Conditions
8%
Celiac Disease Screening
8%
Medicine and Dentistry
Coeliac Disease
100%
Human Leukocyte Antigen
92%
Diagnosis
21%
Rescreening
21%
Diseases
21%
High Risk Population
14%
Population
14%
Assessment of Humans
7%
Environmental Factor
7%
Prevalence
7%
Gastrointestinal Distress
7%
Genetic Risk
7%
Population Research
7%
Immunity
7%
Cost-Effectiveness Analysis
7%
Haplotype
7%
Anemia
7%
Malabsorption
7%
Immunology and Microbiology
Coeliac Disease
100%
Human Leukocyte Antigen
92%
Rescreening
21%
Population
14%
High Risk Population
14%
Population Research
7%
Prevalence
7%
Immunity
7%
Genetic Risk
7%
Haplotype
7%
Pharmacology, Toxicology and Pharmaceutical Science
Coeliac Disease
100%
Leukocyte Antigen
92%
Diseases
21%
Gastrointestinal Symptom
7%
Genetic Risk
7%
Anemia
7%
Population Study
7%
Prevalence
7%
Gluten
7%
Malabsorption
7%
Biochemistry, Genetics and Molecular Biology
Human Leukocyte Antigen
100%
Rescreening
23%
High Risk Population
15%
Population
15%
Prevalence
7%
Genetic Risk
7%
Haplotype
7%
Population Research
7%
Immunity
7%